Loading interface...

Terbitone 250 MG Tablet

Manufactured byGracious Pharmaceuticals
ContainsTerbinafine
Description

Terbitone 250 MG Tablet is an effective antifungal medicine, which may be used to treat fungal infections caused by fungi and certain yeasts such as athlete's foot, jock itch, ringworm infections, onychomycosis (nail fungus), etc. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for Terbitone 250 MG Tablet

  • Diarrhea
  • Fever
  • Headache
  • Joint pain
  • Loss of appetite
  • Nausea or Vomiting
  • Dark urine
  • Yellowing of skin and eyes

Uses of Terbitone 250 MG Tablet

What is it prescribed for?

  • Athlete's foot (Tinea pedis)
  • Jock itch (Tinea cruris)
  • Tinea Corporis (Ringworm infection)
  • Onychomycosis (fungal infection of the nails)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1-2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to terbinafine or any other inactive ingredients present in the formulation.

Liver Disease

This medicine is not recommended for use in patients with active or chronic liver diseases due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Liver Disease

This medicine should be used with caution in patients with a known history of liver diseases due to the increased risk of severe adverse effects. It is contraindicated for use in patients with chronic or active liver diseases. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Allergic skin reactions

This medicine should be used with caution since it may increase the risk of serious skin reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, etc. Report any unusual symptoms to the doctor on priority. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Blood cell count

Use of this medicine may lower the count of certain specific blood cells (neutrophils). Hence, caution is advised for such patients who have a decreased blood cell count. Regular monitoring of blood cell count, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Driving or Operating machinery

Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Use in Children

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact your doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Pimozide

Leflunomide

Codeine

Doxepin

Clozapine

Carvedilol

Duloxetine

Dextromethorphan

Disease interactions

Depression

This medicine should be used with caution in patients with depression due to the increased risk of adverse effects. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Neutropenia

This medicine should be used with caution in patients with neutropenia due to the increased risk of worsening of the patient's condition. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Liver Disease

This medicine is not recommended for use in patients with chronic or active liver diseases due to the increased risk of worsening of the patient's condition. Hence, extreme caution is advised in patients with a known history of liver diseases. Close monitoring of liver function is necessary for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food, as directed by the doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by stopping the production of a certain vital component for the fungal cell wall. This results in disruption of cell membrane formation process and growth of the organism are stunted.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Miscellaneous antifungals

Schedule

Schedule H

Terbinafine | C21H25N - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 17 April 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/1549008#section=Top

Terbinafine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 17 April 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a699061.html

[Internet]. Medicines.org.uk. 2019 [cited 4 October 2019]. Available from:

https://www.medicines.org.uk/emc/files/pil.5922.pdf

Terbinafine - DrugBank [Internet]. Drugbank.ca. 2019 [cited 4 October 2019]. Available from:

https://www.drugbank.ca/drugs/DB00857
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 9 Oct 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.